BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2023, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 15, 2023. The share repurchase authorization permits shares to be repurchased... Read more
Q1 2023 revenues of $685.3 million, up 15.2% year-over-year (yoy); organic revenue up 17.6% yoy Q1 2023 GAAP EPS $0.52; non-GAAP EPS $0.64, up 30.6% yoy Bruker increases FY 2023 guidance for revenue to $2.83-$2.88 billion and for non-GAAP EPS to $2.55-$2.60; implies revenue growth to 12%-14%, and organic revenue growth of 9% – 11%... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, 2023 at 11:00 a.m. (EDT). You can access the webcast of the presentation via the Investors... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2023. First Quarter 2023 Highlights Delivered very strong financial results during the first quarter. First quarter revenue was $10.71 billion, 9% lower versus the same quarter last year.... Read more
WASHINGTON, April 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended March 31, 2023 net earnings were $1.4 billion, or $1.94 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more
Advancements in NMR enable deeper insights into life science, drug discovery, and cleantech ASILOMAR, Calif.–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference (ENC 2023), Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural biology, drug discovery, and battery research. Ascend Evo 400 NMR magnet... Read more
MBT Mycobacteria IVD Kit optimizes sample preparation and comprehensive library of MBT HT Mycobacteria IVD Module MBT HT Filamentous Fungi IVD Module incorporates extensive fungal library with easy and effective sample preparation (MyT) New MBT Compass HT IVD software significantly increases speed for microbial identification, with unique automated self-tuning New LiquidArray® Gastrointestinal PCR Panel detects... Read more
Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology Launch of novel FFPE workflow enables high-throughput, robust and fast processing of tissue samples Bruker and PreOmics to co-commercialize BeatBox workflows ORLANDO, Fla.–(BUSINESS WIRE)– At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow,... Read more